+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 6Years - 50Years
All Genders
ID07318870

Evaluating Probenecid for Cluster Seizures During Anti-Seizure Medication Withdrawal in Presurgical Focal Epilepsy Video-EEG Monitoring

Led by Fondation Ophtalmologique Adolphe de Rothschild · Updated on 2026-10-05

600

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the antiseizure effects of the drug Probenecid PBN in patients with focal epilepsy undergoing presurgical evaluation. The trial targets cluster seizures during anti-seizure medication withdrawal, a critical period with high seizure risk. Probenecid is an old antigout drug repurposed for epilepsy due to its ability to penetrate the brain and block Panx1 channels involved in seizure activity, offering a potentially faster and safer treatment development. Participants will be randomly assigned to receive either oral Probenecid or a placebo. Dosages vary by weight 3g for adults or children over 50 kg, 2g for those between 35 and 50 kg, and 1g for those between 20 and 34 kg. The treatment is administered during video-EEG monitoring in epilepsy monitoring units, where anti-seizure medications may be withdrawn to trigger seizures for evaluation. Throughout the study, participants will be closely monitored with video-EEG to accurately record seizure activity over up to 21 days. Researchers will assess if Probenecid helps stop seizure recurrence during cluster seizures. Safety and efficacy data will be collected during the monitoring period, with participants followed until the studys completion in September 2029.

CONDITIONS

Brief Title

Efficacy of Probenecid on Cluster Seizures During Anti Seizure Medication Withdrawal in Presurgical Focal Epilepsy Video-EEG Monitoring

Research Team

A

Amelie Yavchitz, Dr

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here